Pond Technologies

lockPrivate Group

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases – and our specialized growing systems to cultivate algae and other crops. Our systems effectively close the carbon loop and create wealth from waste.

people4 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Request Membership


Pond Technologies

lockPrivateGroup

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases......

people4 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

2 days ago

8020 Admin posted a press release Pond Technologies Holdings Inc. Announces TSXV Approval of Previously Announced Shares for Debt Settlement and Directors Deferred Share Unit Plan in POND TECHNOLOGIES


MARKHAM, ON, March 2, 2020 /CNW/ - Pond Technologies Holdings Inc. (the "Corporation" or "Pond") (TSX.V: POND) announces that the TSX Venture Exchange ("TSXV") has approved the issuance of 167,783 common shares of Pond in satisfaction of $78,858 in advisory fees owing by Pond to Cross Pond Ventures LLC, all as more previously announced on January 24, 2020.


Pond also announces that the TSXV has accepted a Directors Deferred Share Unit Plan adopted by Pond whereby directors may elect to have all or a portion of their compensation as directors satisfied through the issuance of deferred share units.  The number of such units credited to the directors will be equal to the amount elected divided by the then market price of the Pond shares listed on the TSXV and, upon ceasing to be a director, settlement of the units shall be satisfied through the payment of cash, the issuance of Pond shares, or a combination thereof, as determined by Pond. The plan was previously approved by Pond's shareholders at its annual general and special meeting of shareholders held on June 17, 2019 and the number of Pond shares reserved for issuance under the plan at any time shall not exceed 500,000 Pond shares. As of the date hereof, an aggregate of 484,942 deferred share units have been issued to Pond's directors.


The purpose of the Plan is to attract and retain qualified individuals to serve as directors of the Corporation and to relate such individuals interests more closely to the Corporation's performance and its shareholders.


About Pond Technologies Holdings Inc.:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/March2020/02/c9937.html

Steve Martin, Chief Executive Officer, at s.martin@pondtech.com, 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com, 416-287-3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

15 days ago

8020 Admin posted a press release Pond Technologies announces appointment of Cameron A. Mingay, B.A., LLB as Chairman in POND TECHNOLOGIES


MARKHAM, ON, Feb. 18, 2020 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) (OTC: PNDHF) a company addressing global sustainability challenges of climate change and nutrition, is pleased to announce the appointment of Cameron Mingay as Chairman of the Board. Gerald Quinn, Pond's former Chairman, remains on the board as a director.


Cam Mingay is a senior partner in the Securities Group at Cassels Brock & Blackwell LLP. His diverse practice encompasses M&A, securities, and corporate finance in various industries including: clean tech, natural resources, life science, healthcare, and technology. He has recently turned his focus to generating recommendations to improve ESG (Environmental, Social, Governance) practices in Canada, primarily for the purpose of attracting additional investment dollars into the green technology sector.


Cam has extensive expertise in cross-border legal work. He has been lead counsel on several significant cross-border acquisitions for companies in the natural resources, tech, and cannabis sectors. Cam acts as lead counsel to numerous public clients and serves as counsel to a number of investment dealers on corporate finance matters.


Steve Martin, Pond CEO commented, "We are delighted to welcome Cam Mingay as Pond Chairman. His current focus on developing ESG practices in Canada and extensive experience in cross-border financings will prove invaluable to Pond as we expand our commercial activities to the US and beyond.


In a related development, Pond is also pleased to announce the appointment of Emidio Di Pietro, P.Eng, VP Engineering, as General Manager, Pond Technologies Division. Reporting to the CEO, Mr. DiPietro will oversee all aspects of algae production, sales, and projects within the division. Emidio has comprehensive experience in high volume manufacturing environments, managing several areas of operations such as production, quality assurance and maintenance.


About Pond Technologies Holdings Inc:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/February2020/18/c6623.html

Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release Pond Technologies announces OTC Symbol change to "PNDHF" and DTC eligibility in POND TECHNOLOGIES


MARKHAM, ON, Jan. 29, 2020 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) (OTC: PNDHF) a company addressing global health and wellness challenges of climate change and nutrition, announced today that the Financial Industry Regulatory Authority ("FINRA"), has approved a change in the Company's stock symbol on the OTC Markets.  Effective January 29, 2020, the Company's common shares will begin trading on the OTC Markets under the symbol "PNDHF".  The previous trading symbol was "IOGIF". There is no action required by current shareholders in connection with this change. The Company is also pleased to announce that it has recently secured DTC eligibility by The Depository Trust Company ("DTC") for electronic settlement and transfer of its common shares in the United States.


About Pond Technologies Holdings Inc:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


View original content:http://www.prnewswire.com/news-releases/pond-technologies-announces-otc-symbol-change-to-pndhf-and-dtc-eligibility-300995326.html


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/January2020/29/c5126.html



Steve Martin, Chief Executive Officer, at s.martin@pondtech.com, 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com, 416‐287‐3835 ext. 215.

!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release Pond Technologies announces appointment of Cameron A. Mingay, B.A., LLB, to the Board of Directors and the resignation of Geraldine Kenney-Wallace in POND TECHNOLOGIES


MARKHAM, ON, Jan. 8, 2020 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) (OTC: IOGIF) announced that Ms. Geraldine Kenney-Wallace has resigned from the company's Board of Directors.


In announcing her resignation, Ms. Kenney Wallace cited her recent retirement and relocation to Europe as the reasons for stepping down from Pond's Board of Directors.


"On behalf of the Board and the Company, I would like to thank Geraldine Kenney-Wallace for her time and dedication to Pond over the past 8 years," stated Mr. Gerry Quinn, Pond's Board Chairman. "Geraldine was first elected to Pond's board in 2012 and served as its Chairwoman from 2014 through 2018. We wish her the very best in the future."


Effective immediately, Pond is pleased to announce the appointment of Cameron A. Mingay (Cam) to the Board of Directors.


Cam is a senior partner in the Securities Group at Cassels Brock & Blackwell LLP. Cam's diverse practice encompasses M&A, securities, and corporate finance in various industries, including: clean tech, natural resources, life science, healthcare, technology, and cannabis. He has recently turned his focus to generating recommendations to improve ESG (Environmental, Social, Governance) practices in Canada, primarily for the purpose of attracting additional investment dollars into the green technology sector.


Cam has extensive expertise in cross-border legal work. He has been lead counsel on several significant cross-border acquisitions for companies in the natural resources, tech, and cannabis sectors. Cam acts as lead counsel to numerous public clients and serves as counsel to a number of investment dealers on corporate finance matters.


About Pond Technologies Holdings Inc:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/January2020/08/c7783.html

Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Pond Technologies Holdings Inc. Announces Filing of 2019 Third Quarter Unaudited Condensed Interim Financial Statements and MD&A in POND TECHNOLOGIES


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./

CALGARY, Nov. 25, 2019 /CNW/ - Pond Technologies Holdings Inc. (the "Corporation" or "Pond") (TSX.V: POND) announces that the unaudited condensed interim consolidated financial statements of the Corporation for the three and nine months ended September 30, 2019 and the related management's discussion and analysis have been filed and are available for review on the SEDAR website at www.sedar.com or on the Corporation's website at www.pondtechnologiesinc.com.


The September 30, 2019 unaudited condensed interim consolidated financial statements and management's discussion and analysis documents relate to a period of time after the completion of the reverse take-over and change of business transaction involving the Corporation (previously named Ironhorse Oil & Gas Inc.) and Pond Technologies Inc. which occurred on January 30, 2018.


About Pond Technologies:


Located in Markham, Ontario, Pond has developed a proprietary growth platform that can transform carbon dioxide (CO2) from virtually any source into valuable bio-products.  The Corporation works with the cement, steel, oil and gas and power generation industries to reduce greenhouse gas emissions and generate new revenue streams. 


Pond's platform technology also includes the growth of algae superfoods for the nutraceutical and food additive markets.  Pond's system is capable of growing many species of algae, including strains that produce anti-oxidants, omega-3 fatty acids, and protein for human and animal consumption. 


Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/November2019/25/c8687.html

Chris Cory at c.cory@pondtech.com; Steve Martin at s.martin@pondtech.com or phone 416-287-3835.

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Pond Technologies Holdings Inc. Obtains $2,000,000 Secured Convertible Loan in POND TECHNOLOGIES


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./

Astaxanthin Production Facility to be significantly expanded.

MARKHAM, ON, Nov. 22, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) announces that, on November 22, 2019, it received a loan (the "Loan") in the principal amount of $2,000,000 from Georgian Villas Inc., an entity controlled by one of Pond's directors, Mr. Robert McLeese.


The Loan matures on November 15, 2021, bears interest at 12% per annum, payable quarterly, is convertible, at the option of the lender, into common shares of Pond after the first anniversary date of the Loan at a conversion price of $1.00 per share, and is secured by a first priority interest over all of Pond's present and after-acquired undertaking, property and assets, excluding any equity interests from time to time held by Pond, including of its subsidiaries. As consideration for agreeing to provide the Loan, the lender also received a cash fee equal to 4% ($80,000) of the principal amount of the Loan.


Proceeds of the Loan will be used by Pond for a project to significantly expand the production capacity at its Agassiz, British Columbia, facility. Pond's decision to increase Astaxanthin production is driven by growing commercial interest in both its bulk and Regenurex-branded Astaxanthin products. The balance will be used for general working capital purposes.


As a first step, Pond has successfully implemented process improvements at Agassiz with the application of its proprietary lighting, controls and growth processes to follow immediately.


Steve Martin, Pond CEO commented: "The focused expansion of our Agassiz asset provides us with a clear path to potential positive cash flow over the next several months. We are delighted that customer interest in our branded, bulk and blended Astaxanthin offerings continues to grow as evidenced by our recent agreement with the Toronto Wolfpack Rugby Club and their HowlBrand line of products."


Mr. McLeese currently beneficially owns or controls, indirectly, 1,076,899 (4.75%) of the issued and outstanding common shares of Pond.  Assuming the full conversion of the Loan, Mr. McLeese would hold, indirectly, 3,076,899 (12.47%) of the issued and outstanding common shares of Pond.


The loan transaction is a "related party transaction" under Multilateral Instrument 61-101 – Take-Over Bids and Special Transactions but is exempt from the formal valuation and majority of the minority shareholder approval requirements set forth therein as a result of the fair market value of the Loan not exceeding 25% of Pond's market capitalization.


About Pond Technologies:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Forward Looking Statements


This press release contains forward‐looking statements within the meaning of applicable securities laws, including statements regarding Pond's anticipated use of proceeds of the Loan, expansion of its Agassiz facility, and anticipated cash flow. Such forward‐looking statements are based on certain key expectations and assumptions made by Pond, including, among others, assumptions regarding continued customer interest in Pond's branded, bulk and blended Astaxanthin offerings, the continued legislative (including tax) regime in which Pond and it operating subsidiaries operate, availability of cost-effective labour and supplies, the expansion of the Agassiz facility on time and on budget, the proper functioning of Pond's technology, the quality of the Astaxanthin produced, cash flow and expenses, the successful negotiation of collaboration and marketing agreements, and obtaining and maintaining intellectual property protection. Although Pond believes that the expectations and assumptions on which such forward‐looking statements are based are reasonable, undue reliance should not be placed thereon and Pond can give no assurance that they will prove to be correct. By its nature, such forward‐looking statements are subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed, including the risks referenced above and those set forth in Pond's management's discussion and analysis of financial condition and results of operations for its three and six months ended June 30, 2019, available on the SEDAR website. Readers are cautioned not to place undue reliance on this forward‐looking information, which is given as of the date hereof, and to not use such forward‐looking information for anything other than its intended purpose. Pond does not undertake any obligation to update publicly or revise any forward‐looking information, whether as a result of new information, future events or otherwise, except as required by law.


Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/November2019/22/c9728.html

Chris Cory at c.cory@pondtech.com, or Steve Martin at s.martin@pondtech.com or phone 416-287-3835

!
Thumb 8020 monitor 200200 2

8020 Admin

4 months ago

8020 Admin posted a press release Pond Naturals executes MOU with Toronto Wolfpack's subsidiary, HowlBrands Inc., for the co-development of Astaxanthin sports and wellness products in POND TECHNOLOGIES

CALGARY, Nov. 13, 2019 /PRNewswire/ - Pond Technologies Holdings Inc. ("Pond"), (TSX.V: POND) is pleased to announce that its wholly owned subsidiary, Pond Naturals Inc., ("Naturals") executed an MOU with HowlBrands Inc. ("Howl") on November 8, 2019. Howl, a wholly owned subsidiary of the Toronto Wolfpack Rugby League Football Club ("Toronto Wolfpack"), is developing health and wellness products for global distribution under the 'Rugby Strength' brand.  Howl's current focus is on topical sports recovery products that utilize CBD extracts as active ingredients. Pond Naturals is a provider of high-quality ingredients and formulator of sports and health nutrition products. Naturals is also Canada's only producer of Astaxanthin, a clinically studied algae extract known as 'Nature's most powerful antioxidant' shown to aid in cellular protection and sports recovery. Naturals distributes its Astaxanthin through global bulk sales channels and as a consumer-facing wellness and recovery supplement under its 'Regenurex' brand.


Under the MOU, Pond Naturals has a 12-month exclusive right to develop products that combine the health benefits of CBD with the sports recovery attributes of Astaxanthin. These Astaxanthin-based products are to be marketed globally by Howl under the 'Rugby Strength' brand, and all products containing Pond Naturals ingredients will include the label 'Powered by Pond'.


HowlBrands has marketed the Toronto Wolfpack and "Rugby Strength" brand across multiple platforms including, print, television, radio and social media to markets around the world.  Howl has recently launched its "Rugby Strength" CBD Topical Cream products in the UK with distribution in over 3,000 retail outlets.  Howl's next product launch will include Japan, Australia, New Zealand, Europe, and Asia where it has established media relationships in addition to its global network of amateur rugby clubs.


David Argyle, HowlBrands Inc. CEO remarked:


"We are excited to be working with our partners at Pond on the formulation and marketing of Astaxanthin powered CBD products. Rugby is an incredibly demanding sport where speedy recovery from injury, aches, and pains is crucial to our athletes. As a user of Pond's Regenurex product, I have experienced first-hand, the anti-inflammatory and recovery benefits of Astaxanthin. The Toronto Wolfpack has partnered with world class sports management and community executives, coaches, players, and now the pioneering scientists at Pond, to mobilize its maxim of 'Brand + Brawn + Brains' in our "Rugby Strength" range of products."


Grant Smith, Pond Naturals, President, commented:


"We are very pleased to be working with the Toronto Wolfpack and their subsidiary, HowlBrands on new product development. Pond Naturals' sustainable Canadian Astaxanthin, combined with our proven ability to develop ingredient formulations supports Howl's global reach and vision.  We believe that the 'Powered by Pond' collaboration will benefit the sports, health, and wellness markets that Howl is uniquely situated to address.  Moreover, Howl's emerging position in these verticals will help establish the use of Astaxanthin as the most powerful recovery ingredient in the marketplace."


Forward Looking Statements:


This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding expected results from Pond Naturals. Such forward-looking statements are based on certain key expectations and assumptions made by Pond. Although Pond believes that the expectations and assumptions on which these forward-looking statements are based are reasonable, readers should not place undue reliance on these statements and Pond can give no assurance that they will prove to be correct. Pond does not undertake any obligation to update this forward-looking information except as required by law. For more information visit https://pondtech.com  and review our most recent Managements Discussion & Analysis filed on sedar.com.


About HowlBrands Inc./Rugby Strength:


Wholly owned by the Toronto Wolfpack, HowlBrands Inc. is its global branding and development arm. Positioned at the intersection of sport and wellness, HowlBrands objective is to interact with consumers within, across and beyond rugby and sport. HowlBrands owns a portfolio of athletic-focused non-CBD and CBD-infused products formulated by a team of medical professionals and natural health experts. This includes "Rugby Strength", and its first SKU a recovery body topical cream that is infused with THC-free, Organic Hemp-derived CBD extract. Learn more about Rugby Strength and HowlBrand's product range at: www.rugbystrengthcbd.com


About Toronto Wolfpack:


Toronto Wolfpack is a professional Rugby team competing in the RFL's Super League. We are the first North American team to play in the RFL and the world's first transatlantic professional sports team. The Wolfpack organization is driven by the belief that the world is a better place with more rugby balls in kids' hands. We also aspire to create a global centre for rugby excellence in Toronto, to showcase the best of Ontario by supporting family run local businesses and to actively promote transatlantic trade between North American and UK partners. Learn more about the Toronto Wolfpack at: www.torontowolfpack.com  


About Pond:


Pond provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. Pond, through its subsidiary Pond Naturals Inc., enables consumer brands to source consistent and scalable volumes of sustainable, clean, and nutritious ingredients to serve the rapidly growing demand for high-quality supplements and food. For more information visit https://www.pondtech.com and Pond Naturals Inc.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


View original content:http://www.prnewswire.com/news-releases/pond-naturals-executes-mou-with-toronto-wolfpacks-subsidiary-howlbrands-inc-for-the-co-development-of-astaxanthin-sports-and-wellness-products-300957596.html

!
Thumb 8020 monitor 200200 2

8020 Admin

4 months ago

8020 Admin posted a press release Applied Products Signs Agreement to Sell Pond Naturals' Supplements Including its X10 Pet Supplements in the U.S. in POND TECHNOLOGIES

BEVERLY HILLS, CA / ACCESSWIRE / October 24, 2019 / Applied Products ("Applied" or the "Company"), a division of Applied BioSciences Corp. (OTCQB:APPB) and Pond Technologies Holdings Inc. ("Pond") (TSX.V:POND), announced today that Pond Naturals, Pond's wholly owned subsidiary, has entered a three-year license agreement with Applied Products to expand the distribution of its astaxanthin-based pet supplement to the U.S. As part of the agreement, Pond will sell its X10-branded pet products through Applied Products' established online sales channels.


Applied BioSciences is focused on the development of science-driven biopharmaceuticals and the production of high-quality health and wellness products that target the endocannabinoid system. Through its Applied Products division, the Company currently develops multiple brands offering high quality health and wellness CBD products that conform to the highest regulatory standards and markets through established channels in the US, including its premium pet brand, Herbal Pet.


Grant Smith, Pond Naturals' President, commented, "Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Products shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Herbal Pet consists of a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion. Applied Products intends to sell the Pond Naturals X10 product line alongside Herbal Pet products through its existing e-commerce channels. The Pond X10 product line contains a powerful antioxidant, astaxanthin, extracted from algae at Pond Natural's Agassiz, British Columbia facility. Astaxanthin is a naturally occurring fat-soluble super carotenoid found in certain microalgae with a unique range of health benefits.


"We are excited to introduce X10 to our loyal customer base as a synergistic product to our Herbal Pet CBD product line," Chris Bridges, Board Member of Applied Products, stated. "Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their beloved companion animals."


The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. We also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Safe Harbor Statement


Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Applied Biosciences Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Investor and Media Contact:
IR@appliedbiocorp.com
(833) 475-8247


SOURCE: Applied BioSciences Corp.


View source version on accesswire.com:
https://www.accesswire.com/564002/Applied-Products-Signs-Agreement-to-Sell-Pond-Naturals-Supplements-Including-its-X10-Pet-Supplements-in-the-US

!
Thumb 8020 monitor 200200 2

8020 Admin

5 months ago

8020 Admin posted a press release Pond Technologies subsidiary, PaiGE Growth Technologies Inc., signs MOU with vertical farmer CubicFarm Systems Corp. in POND TECHNOLOGIES


CALGARY, Oct. 21, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond"), (TSX.V: POND) is pleased to announce that on October 18, 2019 its subsidiary PaiGE Growth Technologies Inc. ("PaiGE") entered into a Memorandum of Understanding ("MOU") with CubicFarm Systems Corp. ("CubicFarms") to study the effectiveness of combining CubicFarms vertical farming systems with PaiGE technology. If successful, the partners expect to provide an improved, efficient, modular and readily deployable system to grow vegetables or terrestrial plants using the latest advances in precision agriculture and vertical farming. 


CubicFarms is commercializing industrial-scale vertical farming systems for multiple industries worldwide. The CubicFarms platform consists of a containerized, automated and environment-controlled system where trays of high-value crops like leafy vegetables and herbs follow a patented, undulating path that ensures ideal growing conditions.


Pond has developed a growth platform for algae and terrestrial plants using proprietary lighting, controls and artificial intelligence. Pond has granted PaiGE an exclusive license for the application and further advancement of this technology for terrestrial plants.


As part of the MOU, PaiGE and CubicFarms envisage a multi-phase study to test the improvements from retrofitting the CubicFarms system with PaiGE technology. Each phase shall compare plant growth and resource input in a PaiGE-equipped growth cube against a standard unit – first incorporating proprietary lighting, then sensors, and finally a precision nutrient and water dosing system. In each phase, PaiGE shall provide the engineering design, coordinate equipment manufacturing and installation, and run and assess trials. If the trials prove successful and CubicFarms decides to incorporate PaiGE technology into its growth cubes, CubicFarms agrees to pay PaiGE licensing fees for its technology. PaiGE shall retain intellectual property developed by it throughout the joint project.


Dave Dinesen, CubicFarm's CEO commented: "Our commercial-scale modular CubicFarm growing machines allow our partner farmers to increase local production of nutritious vegetables, herbs, and many other crops, helping to address both food security and the environmental footprint associated with transportation. We're excited to incorporate PaiGE precision technology with the goal of improving resource efficiency and crop yields."


Steve Martin, PaiGE CEO stated: "The partnership with CubicFarms allows us to demonstrate Pond's growth technology in the terrestrial environment, potentially opening the door to a whole new category of applications. CubicFarms is the ideal partner for us to evolve the PaiGE technology as their growth cubes provide a fully controlled environment – similar to Pond algae bioreactors. As a technology provider to CubicFarms, we are excited to support their mission of advancing sustainable precision agriculture and vertical farming."


Forward Looking Statements:


This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding Pond and its subsidiaries and expected results from its subsidiary PaiGE growth environment management systems. Such forward-looking statements are based on certain key expectations and assumptions made by Pond. Although Pond believes that the expectations and assumptions on which these forward-looking statements are based are reasonable, readers should not place undue reliance on these statements and Pond can give no assurance that they will prove to be correct. Pond does not undertake any obligation to update this forward-looking information except as required by law. For more information visit https://www.pondtech.com/paige and review our most recent Managements Discussion & Analysis filed on sedar.com.


About CubicFarm Systems Corp.
CubicFarm® Systems Corp. ("CubicFarms") is an agtech company commercializing large scale, vertical farming solutions for multiple markets worldwide. Founded in 2015, the company's mission is to provide industries around the world with efficient growing systems capable of producing predictable crop yields. Using its unique, patented undulating growing system, CubicFarms solves the two main challenges within the indoor farming industry: high electricity and labour costs. Currently, CubicFarms cultivates living lettuce, living basil and microgreens at its own facility in Pitt Meadows, British Columbia and is partnering with other companies to establish facilities around the world. For more information, visit www.cubicfarms.com.


About Pond Technologies Inc. and PaiGE Growth Technologies Inc:
PaiGE Growth Technologies Inc. ("PaiGE") is an affiliate of Pond Technologies Inc. ("Pond") which has developed lighting, controls and growth platform technology ("Pond Technology") for the growth of algae and cyanobacteria in enclosed bio-reactors.  Pond has granted PaiGE an exclusive license for the application and further development of the Pond Technology for growing terrestrial plants. Pond provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/21/c3687.html



Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

5 months ago

8020 Admin posted a press release Pond Naturals Signs Agreement to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products in POND TECHNOLOGIES


CALGARY, Oct. 17, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) is pleased to announce that Pond Naturals, its wholly owned subsidiary, is expanding the distribution of its astaxanthin-based pet supplement to the US. Pond Naturals has entered a three-year license agreement with Applied BioSciences ("Applied Bio") https://appliedbiocorp.com/ to sell its X10-branded pet products through Applied Bio's online sales channels.


Nevada based Applied Bio develops and markets CBD-based therapeutics and biopharmaceuticals through established channels in the US, including its premium pet brand, Herbal Pet. Applied Bio intends to sell X10 products alongside Herbal Pet products through its existing e-commerce channels.


Herbal Pet has developed a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion (www.HerbalPet.com). X10 is a great complementary product to Herbal Pet as it contains nature's most powerful antioxidant: astaxanthin ('asta-zan-thin'), extracted from algae at Pond Natural's Agassiz, British Columbia facility (www.X10Pet.com).


Like Herbal Pet, X10 targets the premium pet segment, using only natural and vegan ingredients.  


London, UK based research firm, Technavio, estimates that the global pet dietary supplements market will grow by US$624 Million through 2023, or at a 5% CAGR. It identifies the launch of high quality pet dietary supplements as a key driver of this growth.


Chris Bridges, Applied Bio President, stated,


"We are excited to introduce X10 to our loyal customer base as a great complementary product to Herbal Pet's CBD line. While CBD can act quickly in the body, astaxanthin provides long-term relief from chronic conditions, making for an intriguing one-two punch of natural health products. Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their furry family members."


Grant Smith, Pond Naturals President, commented,


"Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Bio shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Studies support astaxanthin supplements (also marketed as "red algae" in the skincare industry) as beneficial for humans and animals alike. The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product and www.Regenurex.com for scientific studies and orders of the pet and human supplements in Canada.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics / biopharmaceuticals and delivering high-quality CBD products as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Forward Looking Statements


This news release contains forward-looking statements within the meaning of applicable securities laws, including statements identified by words such as "focused", "plan", "aimed", "opportunity", "designed", "expected", or similar expressions and includes suggestions of future outcomes, including statements about: plans to pursue vertical integration for high-value algae products; the ability to capture margins through vertical integration; the ability to commercially leverage its facility; the introduction of technology to increase astaxanthin production; the benefit designs of X10 and the ability to capture higher margins from branded consumer products. Although Pond believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will provide to be correct. Readers are cautioned not to place undue reliance on forward-looking statements as actual results may differ materially from those expressed or implied. The factors or assumptions on which the forward-looking statements are based include: the ability to commercialize product at current facilities; the ability to secure appropriate funding or financing; stable or increasing demand for premium consumer products; and the ability to access and implement the technology necessary to achieve expected future results. See www.Regenurex.com and www.X10Pet.com for a summary of condition-specific scientific studies relating to astaxanthin extracted from microalgae.


Additional information about risks, assumptions, uncertainties and other factors that could influence Pond's business is provided in Pond's most recent Management's Discussion & Analysis, available on SEDAR at sedar.com and on Pond's website.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/17/c1603.html

Chris Cory, c.cory@pondtech.com, 416-287-3835 ext. 215; Grant Smith at g.smith@pondtech.com, 416‐287‐3835 ext. 215

!

Pond Technologies

lockPrivate Group

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases – and our specialized growing systems to cultivate algae and other crops. Our systems effectively close the carbon loop and create wealth from waste.

people4 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Request Membership


Pond Technologies

lockPrivateGroup

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases......

people4 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

2 days ago

8020 Admin posted a press release Pond Technologies Holdings Inc. Announces TSXV Approval of Previously Announced Shares for Debt Settlement and Directors Deferred Share Unit Plan in POND TECHNOLOGIES


MARKHAM, ON, March 2, 2020 /CNW/ - Pond Technologies Holdings Inc. (the "Corporation" or "Pond") (TSX.V: POND) announces that the TSX Venture Exchange ("TSXV") has approved the issuance of 167,783 common shares of Pond in satisfaction of $78,858 in advisory fees owing by Pond to Cross Pond Ventures LLC, all as more previously announced on January 24, 2020.


Pond also announces that the TSXV has accepted a Directors Deferred Share Unit Plan adopted by Pond whereby directors may elect to have all or a portion of their compensation as directors satisfied through the issuance of deferred share units.  The number of such units credited to the directors will be equal to the amount elected divided by the then market price of the Pond shares listed on the TSXV and, upon ceasing to be a director, settlement of the units shall be satisfied through the payment of cash, the issuance of Pond shares, or a combination thereof, as determined by Pond. The plan was previously approved by Pond's shareholders at its annual general and special meeting of shareholders held on June 17, 2019 and the number of Pond shares reserved for issuance under the plan at any time shall not exceed 500,000 Pond shares. As of the date hereof, an aggregate of 484,942 deferred share units have been issued to Pond's directors.


The purpose of the Plan is to attract and retain qualified individuals to serve as directors of the Corporation and to relate such individuals interests more closely to the Corporation's performance and its shareholders.


About Pond Technologies Holdings Inc.:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/March2020/02/c9937.html

Steve Martin, Chief Executive Officer, at s.martin@pondtech.com, 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com, 416-287-3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

15 days ago

8020 Admin posted a press release Pond Technologies announces appointment of Cameron A. Mingay, B.A., LLB as Chairman in POND TECHNOLOGIES


MARKHAM, ON, Feb. 18, 2020 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) (OTC: PNDHF) a company addressing global sustainability challenges of climate change and nutrition, is pleased to announce the appointment of Cameron Mingay as Chairman of the Board. Gerald Quinn, Pond's former Chairman, remains on the board as a director.


Cam Mingay is a senior partner in the Securities Group at Cassels Brock & Blackwell LLP. His diverse practice encompasses M&A, securities, and corporate finance in various industries including: clean tech, natural resources, life science, healthcare, and technology. He has recently turned his focus to generating recommendations to improve ESG (Environmental, Social, Governance) practices in Canada, primarily for the purpose of attracting additional investment dollars into the green technology sector.


Cam has extensive expertise in cross-border legal work. He has been lead counsel on several significant cross-border acquisitions for companies in the natural resources, tech, and cannabis sectors. Cam acts as lead counsel to numerous public clients and serves as counsel to a number of investment dealers on corporate finance matters.


Steve Martin, Pond CEO commented, "We are delighted to welcome Cam Mingay as Pond Chairman. His current focus on developing ESG practices in Canada and extensive experience in cross-border financings will prove invaluable to Pond as we expand our commercial activities to the US and beyond.


In a related development, Pond is also pleased to announce the appointment of Emidio Di Pietro, P.Eng, VP Engineering, as General Manager, Pond Technologies Division. Reporting to the CEO, Mr. DiPietro will oversee all aspects of algae production, sales, and projects within the division. Emidio has comprehensive experience in high volume manufacturing environments, managing several areas of operations such as production, quality assurance and maintenance.


About Pond Technologies Holdings Inc:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/February2020/18/c6623.html

Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release Pond Technologies announces OTC Symbol change to "PNDHF" and DTC eligibility in POND TECHNOLOGIES


MARKHAM, ON, Jan. 29, 2020 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) (OTC: PNDHF) a company addressing global health and wellness challenges of climate change and nutrition, announced today that the Financial Industry Regulatory Authority ("FINRA"), has approved a change in the Company's stock symbol on the OTC Markets.  Effective January 29, 2020, the Company's common shares will begin trading on the OTC Markets under the symbol "PNDHF".  The previous trading symbol was "IOGIF". There is no action required by current shareholders in connection with this change. The Company is also pleased to announce that it has recently secured DTC eligibility by The Depository Trust Company ("DTC") for electronic settlement and transfer of its common shares in the United States.


About Pond Technologies Holdings Inc:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


View original content:http://www.prnewswire.com/news-releases/pond-technologies-announces-otc-symbol-change-to-pndhf-and-dtc-eligibility-300995326.html


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/January2020/29/c5126.html



Steve Martin, Chief Executive Officer, at s.martin@pondtech.com, 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com, 416‐287‐3835 ext. 215.

!
Thumb 8020 monitor 200200 2

8020 Admin

2 months ago

8020 Admin posted a press release Pond Technologies announces appointment of Cameron A. Mingay, B.A., LLB, to the Board of Directors and the resignation of Geraldine Kenney-Wallace in POND TECHNOLOGIES


MARKHAM, ON, Jan. 8, 2020 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) (OTC: IOGIF) announced that Ms. Geraldine Kenney-Wallace has resigned from the company's Board of Directors.


In announcing her resignation, Ms. Kenney Wallace cited her recent retirement and relocation to Europe as the reasons for stepping down from Pond's Board of Directors.


"On behalf of the Board and the Company, I would like to thank Geraldine Kenney-Wallace for her time and dedication to Pond over the past 8 years," stated Mr. Gerry Quinn, Pond's Board Chairman. "Geraldine was first elected to Pond's board in 2012 and served as its Chairwoman from 2014 through 2018. We wish her the very best in the future."


Effective immediately, Pond is pleased to announce the appointment of Cameron A. Mingay (Cam) to the Board of Directors.


Cam is a senior partner in the Securities Group at Cassels Brock & Blackwell LLP. Cam's diverse practice encompasses M&A, securities, and corporate finance in various industries, including: clean tech, natural resources, life science, healthcare, technology, and cannabis. He has recently turned his focus to generating recommendations to improve ESG (Environmental, Social, Governance) practices in Canada, primarily for the purpose of attracting additional investment dollars into the green technology sector.


Cam has extensive expertise in cross-border legal work. He has been lead counsel on several significant cross-border acquisitions for companies in the natural resources, tech, and cannabis sectors. Cam acts as lead counsel to numerous public clients and serves as counsel to a number of investment dealers on corporate finance matters.


About Pond Technologies Holdings Inc:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/January2020/08/c7783.html

Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; or Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Pond Technologies Holdings Inc. Announces Filing of 2019 Third Quarter Unaudited Condensed Interim Financial Statements and MD&A in POND TECHNOLOGIES


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./

CALGARY, Nov. 25, 2019 /CNW/ - Pond Technologies Holdings Inc. (the "Corporation" or "Pond") (TSX.V: POND) announces that the unaudited condensed interim consolidated financial statements of the Corporation for the three and nine months ended September 30, 2019 and the related management's discussion and analysis have been filed and are available for review on the SEDAR website at www.sedar.com or on the Corporation's website at www.pondtechnologiesinc.com.


The September 30, 2019 unaudited condensed interim consolidated financial statements and management's discussion and analysis documents relate to a period of time after the completion of the reverse take-over and change of business transaction involving the Corporation (previously named Ironhorse Oil & Gas Inc.) and Pond Technologies Inc. which occurred on January 30, 2018.


About Pond Technologies:


Located in Markham, Ontario, Pond has developed a proprietary growth platform that can transform carbon dioxide (CO2) from virtually any source into valuable bio-products.  The Corporation works with the cement, steel, oil and gas and power generation industries to reduce greenhouse gas emissions and generate new revenue streams. 


Pond's platform technology also includes the growth of algae superfoods for the nutraceutical and food additive markets.  Pond's system is capable of growing many species of algae, including strains that produce anti-oxidants, omega-3 fatty acids, and protein for human and animal consumption. 


Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/November2019/25/c8687.html

Chris Cory at c.cory@pondtech.com; Steve Martin at s.martin@pondtech.com or phone 416-287-3835.

!
Thumb 8020 monitor 200200 2

8020 Admin

3 months ago

8020 Admin posted a press release Pond Technologies Holdings Inc. Obtains $2,000,000 Secured Convertible Loan in POND TECHNOLOGIES


/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./

Astaxanthin Production Facility to be significantly expanded.

MARKHAM, ON, Nov. 22, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) announces that, on November 22, 2019, it received a loan (the "Loan") in the principal amount of $2,000,000 from Georgian Villas Inc., an entity controlled by one of Pond's directors, Mr. Robert McLeese.


The Loan matures on November 15, 2021, bears interest at 12% per annum, payable quarterly, is convertible, at the option of the lender, into common shares of Pond after the first anniversary date of the Loan at a conversion price of $1.00 per share, and is secured by a first priority interest over all of Pond's present and after-acquired undertaking, property and assets, excluding any equity interests from time to time held by Pond, including of its subsidiaries. As consideration for agreeing to provide the Loan, the lender also received a cash fee equal to 4% ($80,000) of the principal amount of the Loan.


Proceeds of the Loan will be used by Pond for a project to significantly expand the production capacity at its Agassiz, British Columbia, facility. Pond's decision to increase Astaxanthin production is driven by growing commercial interest in both its bulk and Regenurex-branded Astaxanthin products. The balance will be used for general working capital purposes.


As a first step, Pond has successfully implemented process improvements at Agassiz with the application of its proprietary lighting, controls and growth processes to follow immediately.


Steve Martin, Pond CEO commented: "The focused expansion of our Agassiz asset provides us with a clear path to potential positive cash flow over the next several months. We are delighted that customer interest in our branded, bulk and blended Astaxanthin offerings continues to grow as evidenced by our recent agreement with the Toronto Wolfpack Rugby Club and their HowlBrand line of products."


Mr. McLeese currently beneficially owns or controls, indirectly, 1,076,899 (4.75%) of the issued and outstanding common shares of Pond.  Assuming the full conversion of the Loan, Mr. McLeese would hold, indirectly, 3,076,899 (12.47%) of the issued and outstanding common shares of Pond.


The loan transaction is a "related party transaction" under Multilateral Instrument 61-101 – Take-Over Bids and Special Transactions but is exempt from the formal valuation and majority of the minority shareholder approval requirements set forth therein as a result of the fair market value of the Loan not exceeding 25% of Pond's market capitalization.


About Pond Technologies:


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. This enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Forward Looking Statements


This press release contains forward‐looking statements within the meaning of applicable securities laws, including statements regarding Pond's anticipated use of proceeds of the Loan, expansion of its Agassiz facility, and anticipated cash flow. Such forward‐looking statements are based on certain key expectations and assumptions made by Pond, including, among others, assumptions regarding continued customer interest in Pond's branded, bulk and blended Astaxanthin offerings, the continued legislative (including tax) regime in which Pond and it operating subsidiaries operate, availability of cost-effective labour and supplies, the expansion of the Agassiz facility on time and on budget, the proper functioning of Pond's technology, the quality of the Astaxanthin produced, cash flow and expenses, the successful negotiation of collaboration and marketing agreements, and obtaining and maintaining intellectual property protection. Although Pond believes that the expectations and assumptions on which such forward‐looking statements are based are reasonable, undue reliance should not be placed thereon and Pond can give no assurance that they will prove to be correct. By its nature, such forward‐looking statements are subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed, including the risks referenced above and those set forth in Pond's management's discussion and analysis of financial condition and results of operations for its three and six months ended June 30, 2019, available on the SEDAR website. Readers are cautioned not to place undue reliance on this forward‐looking information, which is given as of the date hereof, and to not use such forward‐looking information for anything other than its intended purpose. Pond does not undertake any obligation to update publicly or revise any forward‐looking information, whether as a result of new information, future events or otherwise, except as required by law.


Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/November2019/22/c9728.html

Chris Cory at c.cory@pondtech.com, or Steve Martin at s.martin@pondtech.com or phone 416-287-3835

!
Thumb 8020 monitor 200200 2

8020 Admin

4 months ago

8020 Admin posted a press release Pond Naturals executes MOU with Toronto Wolfpack's subsidiary, HowlBrands Inc., for the co-development of Astaxanthin sports and wellness products in POND TECHNOLOGIES

CALGARY, Nov. 13, 2019 /PRNewswire/ - Pond Technologies Holdings Inc. ("Pond"), (TSX.V: POND) is pleased to announce that its wholly owned subsidiary, Pond Naturals Inc., ("Naturals") executed an MOU with HowlBrands Inc. ("Howl") on November 8, 2019. Howl, a wholly owned subsidiary of the Toronto Wolfpack Rugby League Football Club ("Toronto Wolfpack"), is developing health and wellness products for global distribution under the 'Rugby Strength' brand.  Howl's current focus is on topical sports recovery products that utilize CBD extracts as active ingredients. Pond Naturals is a provider of high-quality ingredients and formulator of sports and health nutrition products. Naturals is also Canada's only producer of Astaxanthin, a clinically studied algae extract known as 'Nature's most powerful antioxidant' shown to aid in cellular protection and sports recovery. Naturals distributes its Astaxanthin through global bulk sales channels and as a consumer-facing wellness and recovery supplement under its 'Regenurex' brand.


Under the MOU, Pond Naturals has a 12-month exclusive right to develop products that combine the health benefits of CBD with the sports recovery attributes of Astaxanthin. These Astaxanthin-based products are to be marketed globally by Howl under the 'Rugby Strength' brand, and all products containing Pond Naturals ingredients will include the label 'Powered by Pond'.


HowlBrands has marketed the Toronto Wolfpack and "Rugby Strength" brand across multiple platforms including, print, television, radio and social media to markets around the world.  Howl has recently launched its "Rugby Strength" CBD Topical Cream products in the UK with distribution in over 3,000 retail outlets.  Howl's next product launch will include Japan, Australia, New Zealand, Europe, and Asia where it has established media relationships in addition to its global network of amateur rugby clubs.


David Argyle, HowlBrands Inc. CEO remarked:


"We are excited to be working with our partners at Pond on the formulation and marketing of Astaxanthin powered CBD products. Rugby is an incredibly demanding sport where speedy recovery from injury, aches, and pains is crucial to our athletes. As a user of Pond's Regenurex product, I have experienced first-hand, the anti-inflammatory and recovery benefits of Astaxanthin. The Toronto Wolfpack has partnered with world class sports management and community executives, coaches, players, and now the pioneering scientists at Pond, to mobilize its maxim of 'Brand + Brawn + Brains' in our "Rugby Strength" range of products."


Grant Smith, Pond Naturals, President, commented:


"We are very pleased to be working with the Toronto Wolfpack and their subsidiary, HowlBrands on new product development. Pond Naturals' sustainable Canadian Astaxanthin, combined with our proven ability to develop ingredient formulations supports Howl's global reach and vision.  We believe that the 'Powered by Pond' collaboration will benefit the sports, health, and wellness markets that Howl is uniquely situated to address.  Moreover, Howl's emerging position in these verticals will help establish the use of Astaxanthin as the most powerful recovery ingredient in the marketplace."


Forward Looking Statements:


This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding expected results from Pond Naturals. Such forward-looking statements are based on certain key expectations and assumptions made by Pond. Although Pond believes that the expectations and assumptions on which these forward-looking statements are based are reasonable, readers should not place undue reliance on these statements and Pond can give no assurance that they will prove to be correct. Pond does not undertake any obligation to update this forward-looking information except as required by law. For more information visit https://pondtech.com  and review our most recent Managements Discussion & Analysis filed on sedar.com.


About HowlBrands Inc./Rugby Strength:


Wholly owned by the Toronto Wolfpack, HowlBrands Inc. is its global branding and development arm. Positioned at the intersection of sport and wellness, HowlBrands objective is to interact with consumers within, across and beyond rugby and sport. HowlBrands owns a portfolio of athletic-focused non-CBD and CBD-infused products formulated by a team of medical professionals and natural health experts. This includes "Rugby Strength", and its first SKU a recovery body topical cream that is infused with THC-free, Organic Hemp-derived CBD extract. Learn more about Rugby Strength and HowlBrand's product range at: www.rugbystrengthcbd.com


About Toronto Wolfpack:


Toronto Wolfpack is a professional Rugby team competing in the RFL's Super League. We are the first North American team to play in the RFL and the world's first transatlantic professional sports team. The Wolfpack organization is driven by the belief that the world is a better place with more rugby balls in kids' hands. We also aspire to create a global centre for rugby excellence in Toronto, to showcase the best of Ontario by supporting family run local businesses and to actively promote transatlantic trade between North American and UK partners. Learn more about the Toronto Wolfpack at: www.torontowolfpack.com  


About Pond:


Pond provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. Pond, through its subsidiary Pond Naturals Inc., enables consumer brands to source consistent and scalable volumes of sustainable, clean, and nutritious ingredients to serve the rapidly growing demand for high-quality supplements and food. For more information visit https://www.pondtech.com and Pond Naturals Inc.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


View original content:http://www.prnewswire.com/news-releases/pond-naturals-executes-mou-with-toronto-wolfpacks-subsidiary-howlbrands-inc-for-the-co-development-of-astaxanthin-sports-and-wellness-products-300957596.html

!
Thumb 8020 monitor 200200 2

8020 Admin

4 months ago

8020 Admin posted a press release Applied Products Signs Agreement to Sell Pond Naturals' Supplements Including its X10 Pet Supplements in the U.S. in POND TECHNOLOGIES

BEVERLY HILLS, CA / ACCESSWIRE / October 24, 2019 / Applied Products ("Applied" or the "Company"), a division of Applied BioSciences Corp. (OTCQB:APPB) and Pond Technologies Holdings Inc. ("Pond") (TSX.V:POND), announced today that Pond Naturals, Pond's wholly owned subsidiary, has entered a three-year license agreement with Applied Products to expand the distribution of its astaxanthin-based pet supplement to the U.S. As part of the agreement, Pond will sell its X10-branded pet products through Applied Products' established online sales channels.


Applied BioSciences is focused on the development of science-driven biopharmaceuticals and the production of high-quality health and wellness products that target the endocannabinoid system. Through its Applied Products division, the Company currently develops multiple brands offering high quality health and wellness CBD products that conform to the highest regulatory standards and markets through established channels in the US, including its premium pet brand, Herbal Pet.


Grant Smith, Pond Naturals' President, commented, "Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Products shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Herbal Pet consists of a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion. Applied Products intends to sell the Pond Naturals X10 product line alongside Herbal Pet products through its existing e-commerce channels. The Pond X10 product line contains a powerful antioxidant, astaxanthin, extracted from algae at Pond Natural's Agassiz, British Columbia facility. Astaxanthin is a naturally occurring fat-soluble super carotenoid found in certain microalgae with a unique range of health benefits.


"We are excited to introduce X10 to our loyal customer base as a synergistic product to our Herbal Pet CBD product line," Chris Bridges, Board Member of Applied Products, stated. "Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their beloved companion animals."


The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. We also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Safe Harbor Statement


Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Applied Biosciences Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Investor and Media Contact:
IR@appliedbiocorp.com
(833) 475-8247


SOURCE: Applied BioSciences Corp.


View source version on accesswire.com:
https://www.accesswire.com/564002/Applied-Products-Signs-Agreement-to-Sell-Pond-Naturals-Supplements-Including-its-X10-Pet-Supplements-in-the-US

!
Thumb 8020 monitor 200200 2

8020 Admin

5 months ago

8020 Admin posted a press release Pond Technologies subsidiary, PaiGE Growth Technologies Inc., signs MOU with vertical farmer CubicFarm Systems Corp. in POND TECHNOLOGIES


CALGARY, Oct. 21, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond"), (TSX.V: POND) is pleased to announce that on October 18, 2019 its subsidiary PaiGE Growth Technologies Inc. ("PaiGE") entered into a Memorandum of Understanding ("MOU") with CubicFarm Systems Corp. ("CubicFarms") to study the effectiveness of combining CubicFarms vertical farming systems with PaiGE technology. If successful, the partners expect to provide an improved, efficient, modular and readily deployable system to grow vegetables or terrestrial plants using the latest advances in precision agriculture and vertical farming. 


CubicFarms is commercializing industrial-scale vertical farming systems for multiple industries worldwide. The CubicFarms platform consists of a containerized, automated and environment-controlled system where trays of high-value crops like leafy vegetables and herbs follow a patented, undulating path that ensures ideal growing conditions.


Pond has developed a growth platform for algae and terrestrial plants using proprietary lighting, controls and artificial intelligence. Pond has granted PaiGE an exclusive license for the application and further advancement of this technology for terrestrial plants.


As part of the MOU, PaiGE and CubicFarms envisage a multi-phase study to test the improvements from retrofitting the CubicFarms system with PaiGE technology. Each phase shall compare plant growth and resource input in a PaiGE-equipped growth cube against a standard unit – first incorporating proprietary lighting, then sensors, and finally a precision nutrient and water dosing system. In each phase, PaiGE shall provide the engineering design, coordinate equipment manufacturing and installation, and run and assess trials. If the trials prove successful and CubicFarms decides to incorporate PaiGE technology into its growth cubes, CubicFarms agrees to pay PaiGE licensing fees for its technology. PaiGE shall retain intellectual property developed by it throughout the joint project.


Dave Dinesen, CubicFarm's CEO commented: "Our commercial-scale modular CubicFarm growing machines allow our partner farmers to increase local production of nutritious vegetables, herbs, and many other crops, helping to address both food security and the environmental footprint associated with transportation. We're excited to incorporate PaiGE precision technology with the goal of improving resource efficiency and crop yields."


Steve Martin, PaiGE CEO stated: "The partnership with CubicFarms allows us to demonstrate Pond's growth technology in the terrestrial environment, potentially opening the door to a whole new category of applications. CubicFarms is the ideal partner for us to evolve the PaiGE technology as their growth cubes provide a fully controlled environment – similar to Pond algae bioreactors. As a technology provider to CubicFarms, we are excited to support their mission of advancing sustainable precision agriculture and vertical farming."


Forward Looking Statements:


This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding Pond and its subsidiaries and expected results from its subsidiary PaiGE growth environment management systems. Such forward-looking statements are based on certain key expectations and assumptions made by Pond. Although Pond believes that the expectations and assumptions on which these forward-looking statements are based are reasonable, readers should not place undue reliance on these statements and Pond can give no assurance that they will prove to be correct. Pond does not undertake any obligation to update this forward-looking information except as required by law. For more information visit https://www.pondtech.com/paige and review our most recent Managements Discussion & Analysis filed on sedar.com.


About CubicFarm Systems Corp.
CubicFarm® Systems Corp. ("CubicFarms") is an agtech company commercializing large scale, vertical farming solutions for multiple markets worldwide. Founded in 2015, the company's mission is to provide industries around the world with efficient growing systems capable of producing predictable crop yields. Using its unique, patented undulating growing system, CubicFarms solves the two main challenges within the indoor farming industry: high electricity and labour costs. Currently, CubicFarms cultivates living lettuce, living basil and microgreens at its own facility in Pitt Meadows, British Columbia and is partnering with other companies to establish facilities around the world. For more information, visit www.cubicfarms.com.


About Pond Technologies Inc. and PaiGE Growth Technologies Inc:
PaiGE Growth Technologies Inc. ("PaiGE") is an affiliate of Pond Technologies Inc. ("Pond") which has developed lighting, controls and growth platform technology ("Pond Technology") for the growth of algae and cyanobacteria in enclosed bio-reactors.  Pond has granted PaiGE an exclusive license for the application and further development of the Pond Technology for growing terrestrial plants. Pond provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/21/c3687.html



Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

5 months ago

8020 Admin posted a press release Pond Naturals Signs Agreement to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products in POND TECHNOLOGIES


CALGARY, Oct. 17, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) is pleased to announce that Pond Naturals, its wholly owned subsidiary, is expanding the distribution of its astaxanthin-based pet supplement to the US. Pond Naturals has entered a three-year license agreement with Applied BioSciences ("Applied Bio") https://appliedbiocorp.com/ to sell its X10-branded pet products through Applied Bio's online sales channels.


Nevada based Applied Bio develops and markets CBD-based therapeutics and biopharmaceuticals through established channels in the US, including its premium pet brand, Herbal Pet. Applied Bio intends to sell X10 products alongside Herbal Pet products through its existing e-commerce channels.


Herbal Pet has developed a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion (www.HerbalPet.com). X10 is a great complementary product to Herbal Pet as it contains nature's most powerful antioxidant: astaxanthin ('asta-zan-thin'), extracted from algae at Pond Natural's Agassiz, British Columbia facility (www.X10Pet.com).


Like Herbal Pet, X10 targets the premium pet segment, using only natural and vegan ingredients.  


London, UK based research firm, Technavio, estimates that the global pet dietary supplements market will grow by US$624 Million through 2023, or at a 5% CAGR. It identifies the launch of high quality pet dietary supplements as a key driver of this growth.


Chris Bridges, Applied Bio President, stated,


"We are excited to introduce X10 to our loyal customer base as a great complementary product to Herbal Pet's CBD line. While CBD can act quickly in the body, astaxanthin provides long-term relief from chronic conditions, making for an intriguing one-two punch of natural health products. Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their furry family members."


Grant Smith, Pond Naturals President, commented,


"Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Bio shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Studies support astaxanthin supplements (also marketed as "red algae" in the skincare industry) as beneficial for humans and animals alike. The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product and www.Regenurex.com for scientific studies and orders of the pet and human supplements in Canada.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics / biopharmaceuticals and delivering high-quality CBD products as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Forward Looking Statements


This news release contains forward-looking statements within the meaning of applicable securities laws, including statements identified by words such as "focused", "plan", "aimed", "opportunity", "designed", "expected", or similar expressions and includes suggestions of future outcomes, including statements about: plans to pursue vertical integration for high-value algae products; the ability to capture margins through vertical integration; the ability to commercially leverage its facility; the introduction of technology to increase astaxanthin production; the benefit designs of X10 and the ability to capture higher margins from branded consumer products. Although Pond believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will provide to be correct. Readers are cautioned not to place undue reliance on forward-looking statements as actual results may differ materially from those expressed or implied. The factors or assumptions on which the forward-looking statements are based include: the ability to commercialize product at current facilities; the ability to secure appropriate funding or financing; stable or increasing demand for premium consumer products; and the ability to access and implement the technology necessary to achieve expected future results. See www.Regenurex.com and www.X10Pet.com for a summary of condition-specific scientific studies relating to astaxanthin extracted from microalgae.


Additional information about risks, assumptions, uncertainties and other factors that could influence Pond's business is provided in Pond's most recent Management's Discussion & Analysis, available on SEDAR at sedar.com and on Pond's website.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/17/c1603.html

Chris Cory, c.cory@pondtech.com, 416-287-3835 ext. 215; Grant Smith at g.smith@pondtech.com, 416‐287‐3835 ext. 215

!